The HBeAg-Negative “Gray Zone” Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients?
Volume: 18, Issue: 1, Pages: 263 - 264
Published: Jan 1, 2020
Abstract
One of the main goals of antiviral therapy in hepatitis B virus (HBV)–infected patients is to prevent the progression to hepatic cirrhosis and reduce the risk of hepatocellular carcinoma (HCC). We have read with interest the paper by Lee et al1Lee H.W. et al.Clin Gastroenterol Hepatol. 2019; 17: 2808-2810.e2Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar dealing with a challenging therapeutic scenario in which patients do not...
Paper Details
Title
The HBeAg-Negative “Gray Zone” Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients?
Published Date
Jan 1, 2020
Volume
18
Issue
1
Pages
263 - 264
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History